Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 37.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,216 shares of the company's stock after selling 8,524 shares during the quarter. State of Alaska Department of Revenue's holdings in Henry Schein were worth $983,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. ING Groep NV purchased a new position in shares of Henry Schein in the 3rd quarter valued at $63,226,000. Holocene Advisors LP purchased a new position in shares of Henry Schein in the 3rd quarter valued at $58,319,000. Southpoint Capital Advisors LP grew its position in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock valued at $189,540,000 after buying an additional 600,000 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Henry Schein in the 3rd quarter valued at $43,740,000. Finally, Bank of Montreal Can grew its position in shares of Henry Schein by 365.6% in the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock valued at $52,095,000 after buying an additional 558,689 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on HSIC shares. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 target price on the stock. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday. They set an "equal weight" rating and a $80.00 price objective on the stock. Finally, Barrington Research raised their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the stock an "outperform" rating in a research report on Thursday, January 30th. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $80.09.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded down $1.62 during midday trading on Monday, hitting $76.00. The stock had a trading volume of 1,455,207 shares, compared to its average volume of 1,474,978. The company has a market capitalization of $9.48 billion, a PE ratio of 31.28, a P/E/G ratio of 2.21 and a beta of 0.91. The stock has a 50 day moving average price of $74.03 and a two-hundred day moving average price of $72.02. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.